Cargando…
Acute leukemia in the time of COVID-19
Autores principales: | Gavillet, Mathilde, Carr Klappert, Jeanette, Spertini, Olivier, Blum, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138175/ https://www.ncbi.nlm.nih.gov/pubmed/32251934 http://dx.doi.org/10.1016/j.leukres.2020.106353 |
Ejemplares similares
-
Daratumumab and venetoclax in combination with chemotherapy provide sustained molecular remission in relapsed/refractory CD19, CD20, and CD22 negative acute B lymphoblastic leukemia with KMT2A-AFF1 transcript
por: Voruz, Sophie, et al.
Publicado: (2021) -
T315I clone selection in a Ph+ all patient under low‐dose ponatinib maintenance
por: Noetzli, Jasmine, et al.
Publicado: (2017) -
Acute Myeloid and Lymphoblastic Leukemia Cell Interactions with Endothelial Selectins: Critical Role of PSGL-1, CD44 and CD43
por: Spertini, Caroline, et al.
Publicado: (2019) -
Using Digital RNA Counting and Flow Cytometry to Compare mRNA with Protein Expression in Acute Leukemias
por: Fernandez, Paula, et al.
Publicado: (2012) -
Isolated skin infiltration by a blastic plasmacytoid dendritic cell neoplasm
por: Stalder, Grégoire, et al.
Publicado: (2022)